Molecular Characterization of Circulating Tumor Cells isolated with GILUPI Technology from Prostate Cancer Patients
GILUPI GmbH announces the recent publication of a clinical study demonstrating multiplex gene expression profiling of circulating tumor cells (CTCs) isolated in vivo from high-risk prostate cancer patients by the use of GILUPI CellCollector® [1]. Prostate cancer is a very Mehr